Ginwa Enterprise GroupSHSE:600080 -1.20%47 OCF Yield % is 5.00 as of Jul. 06, 2026, which is 310% above its 10-year median of 1.22. GuruFocus rates SHSE:600080 with a GF Score™ of 47/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Ginwa Enterprise Group ranks better than 59.78% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ginwa Enterprise Group OCF Yield % Related Terms
Ginwa Enterprise Group OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginwa Enterprise Group OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Ginwa Enterprise Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginwa Enterprise Group (SHSE:600080) has a OCF Yield % of 5.00 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ginwa Enterprise Group and its competitors. This is 310% above median its historical median of 1.22. According to the industry distribution chart, Ginwa Enterprise Group ranks #405 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 40.2%.
Is Ginwa Enterprise Group's OCF Yield % too high?
Ginwa Enterprise Group's current OCF Yield % of 5.00 is 310% above median its 10-year median of 1.22. The Drug Manufacturers industry median OCF Yield % is 3.41. Ginwa Enterprise Group's value of 5.00 is 46.6% above this industry median. Based on the distribution chart, Ginwa Enterprise Group ranks #405 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ginwa Enterprise Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ginwa Enterprise Group ranks #405 out of 1007 companies for OCF Yield %. This puts Ginwa Enterprise Group in the upper half of its industry. The industry median OCF Yield % is 3.41. Ginwa Enterprise Group's value of 5.00 is 46.6% above this benchmark. While the company's 10-year median is 1.22 vs. the industry median of 3.41, Ginwa Enterprise Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.41, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginwa Enterprise Group's current OCF Yield % of 5.00 is 46.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ginwa Enterprise Group and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginwa Enterprise Group's current OCF Yield % is 5.00, which is 310% above median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.94 — trading 34.4% below its estimated fair value. The current OCF Yield % is 5.00, which is 310% above median its 10-year median of 1.22 and 46.6% above the Drug Manufacturers industry median of 3.41. Ginwa Enterprise Group's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current OCF Yield % is 5.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?
Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued.
The current stock price of ¥4.94 is trading 34.4% below its estimated GF Value™ of ¥7.53.
GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.
Key valuation signals for SHSE:600080:
OCF Yield %: 5.00 (310% above median its 10-year median of 1.22)
GF Value™: ¥7.53 vs. price of ¥4.94 (34.4% below fair value)
Industry Position: 46.6% above the Drug Manufacturers median (#405 of 1007)
No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
47GF Score
Get the complete analysis for SHSE:600080
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600080 has been successfully added to your 
